Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tam T. Guyene"'
Autor:
Tam T. Guyene, Hollis D. Kleinert, Joël Ménard, Robert S. Boger, Harriet N. Glassman, Denise M. Moyse
Publikováno v:
Circulation. 91(2)
Background Zankiren HCl (A-72517) is a potent renin inhibitor shown to have substantial bioavailability in several animal species and to produce dose-related reductions in blood pressure, plasma renin activity, and angiotensin II (Ang II) in salt-dep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d3af5d177d73f4cdd4bbf9bc38e4789
https://pubmed.ncbi.nlm.nih.gov/7805235
https://pubmed.ncbi.nlm.nih.gov/7805235
Autor:
Marc Thibonnier, Jean-Claude Aldigier, Tam T. Guyene, Pierre Corvol, Pierre-François Plouin, Joël Ménard
Publikováno v:
The American Journal of Cardiology. 49:1447-1452
Captopril was administered for 6 days to 26 severely hypertensive hospitalized patients, 17 with essential hypertension and 9 with renovascular hypertension. All the patients were on a low sodium diet and were treated after the 3rd day in the hospita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::796654a702a6773cec1993c9caa1378e
https://doi.org/10.1016/0002-9149(82)90359-9
https://doi.org/10.1016/0002-9149(82)90359-9
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 58:143-148
Hyporeninemic hypoaldosteronism was found in two male siblings with urinary salt wasting and low plasma sodium levels. The eldest, aged 1 yr, had growth retardation, with hyponatremia and normal plasma potassium levels. The second, aged 2 months, had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f8bd446b3fb9eff5a6538cd64987aa6
https://doi.org/10.1210/jcem-58-1-143
https://doi.org/10.1210/jcem-58-1-143
Autor:
Jürg Nussberger, Hans R. Brunner, Tam T. Guyene, Pierre Corvol, Joël Ménard, Xavier Jeunemaitre
Publikováno v:
American journal of hypertension, vol. 2, no. 11 Pt 1, pp. 819-827
The new renin inhibitor CGP 38560A has been shown to block angiotensin (ANG) production in healthy volunteers. In order to determine its potential antihypertensive effect, the compound was administered in a 30-min infusion, in 12 hypertensive patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd6b62d95aea6b7aaad8bcc942cb3a3e
https://pubmed.ncbi.nlm.nih.gov/2686709
https://pubmed.ncbi.nlm.nih.gov/2686709
Autor:
Azizi M; Centre d'Investigations Cliniques 9201, Assistance Publique des Hôpitaux de Paris et INSERM, Hôpital Européen Georges Pompidou, 20-40 rue Leblanc, 75908 Paris cedex 15, France. michel.azizi@egp.ap-hop-paris.fr, Junot C, Ezan E, Hallouin MC, Guyene T, Ménard J
Publikováno v:
Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2002 Aug; Vol. 80 (8), pp. 492-8. Date of Electronic Publication: 2002 Jun 22.